CME Group (CME)

EBITDA Margin

81.71%

TTM · Period ending:

CME logo

CME EBITDA Margin

Latest reported81.71%
CME TTM EBITDA Margin (38.54% → 81.71%)
High-resolution chart · PNG

CME ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

CME Group EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
81.7086%
89.4442%
88.5839%
83.646%
82.9981%
82.2579%
82.2026%
81.9047%
81.9595%
82.1073%
83.6294%
83.9922%
84.0035%
83.1065%
80.0016%
80.532%
87.1101%
85.3983%
83.7132%
79.4544%
68.298%
67.2163%
68.6522%
69.8223%
70.8717%
70.6612%
68.6298%
67.8708%
68.4527%
71.1301%
73.8896%
76.2107%
77.1354%
76.6709%
78.2451%
78.7402%
78.3705%
76.8849%
73.3311%
71.6942%
70.5738%
68.9495%
69.2197%
68.8113%
68.024%
69.1264%
68.241%
66.6103%
66.9587%
68.2715%
67.7894%
70.1773%
70.6857%
71.1397%
71.3202%
69.7746%
70.4137%
69.4317%
70.5328%
71.829%
71.1322%
71.0608%
70.5863%
70.3783%
70.1027%
70.1681%
69.8905%
70.7594%
71.9664%
71.5514%
72.0747%
72.5315%
71.5266%
71.0709%
69.8125%
67.4624%
65.3497%
65.5216%
64.4598%
64.7467%
64.0829%
63.4736%
63.3209%
62.2001%
62.0472%
60.3851%
58.9261%
56.1109%
53.459%
50.7829%
48.3435%
49.8247%
47.6197%
46.4555%
45.225%
40.8671%
41.7998%
38.5441%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.